secwatch.observer — SEC 8-K summary
======================================

Issuer:     WINDTREE THERAPEUTICS INC /DE/ (WINT)
CIK:        0000946486
Form:       8-K
Filed at:   2024-09-24T23:59:59+00:00
Accession:  0001437749-24-029915
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Windtree shareholders approve all proposals at annual meeting, including equity issuances
--------------------------------------------------------------------------------

- Elected directors Fraser, Latkin, Pelletier, Strobeck with >258,000 votes each; broker non-votes 112,534.
- Advisory say-on-pay approved: 252,693 for, 11,061 against, 8,795 abstentions, 112,534 broker non-votes.
- Ratified EisnerAmper as 2024 auditor: 368,203 for, 7,737 against, 9,143 abstentions (no broker non-votes).
- Approved share issuance under committed equity financing (255,211 for, 8,648 against) per Nasdaq Rule 5635(d).
- Approved conversion of Series C Preferred (initial conv. price $3.74, floor $1.28) and warrant exercise ($4.11): 251,535 for.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/946486/000143774924029915/0001437749-24-029915-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/946486/000143774924029915/wint20240924_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-24-029915

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer